Cytodyn has shown statistically significant efficacy in their Phase 3 HIV combination therapy trial. We need to package that data into an acceptable form and submit the BLA, said Cap'n Obvious.

I'm glad Dr. Sacha keeps working hard and I'm glad the company PR'd the info. Did anyone expect pre-clinical research news to bump our share price?